These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1133 related articles for article (PubMed ID: 30818914)
1. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection]. Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914 [No Abstract] [Full Text] [Related]
2. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection]. Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915 [No Abstract] [Full Text] [Related]
3. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789 [No Abstract] [Full Text] [Related]
4. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients. Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234 [TBL] [Abstract][Full Text] [Related]
5. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis]. Shi H; Li XY; Zhu JY; Lin CS; Zhang Y Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):721-725. PubMed ID: 29108198 [No Abstract] [Full Text] [Related]
6. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus. Liu J; Wang J; Jin D; Qi C; Yan T; Cao F; Jin L; Tian Z; Guo D; Yuan N; Feng W; Zhang S; Zhao Y; Chen T J Gastroenterol Hepatol; 2017 Jan; 32(1):177-183. PubMed ID: 27161163 [TBL] [Abstract][Full Text] [Related]
7. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal]. Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623 [TBL] [Abstract][Full Text] [Related]
8. [Establish a predictive modeling under antiviral therapy for hepatitis B e antigen seroconversion in chronic hepatitis B]. Liu GW; Tang KC; Li Q; Lu W Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):641-645. PubMed ID: 30481858 [No Abstract] [Full Text] [Related]
9. [Clinical study on liver function, virology, serological changes and the safety of drug withdrawal in pregnant women who are chronic HBV carriers during pregnancy and postpartum]. Wang XX; Lu JF; Wu YL; Ma LN; Jin Y; Cao ZH; Ren S; Liu YL; Zheng YY; Chen XY Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):261-266. PubMed ID: 31082336 [No Abstract] [Full Text] [Related]
10. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. Lok AS; Trinh H; Carosi G; Akarca US; Gadano A; Habersetzer F; Sievert W; Wong D; Lovegren M; Cohen D; Llamoso C Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China. Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589 [No Abstract] [Full Text] [Related]
12. [Analysis of efficacy and factors influencing sequential combination therapy with tenofovir alafenamide fumarate after treatment with entecavir in chronic hepatitis B patients with low-level viremia]. Liu LP; Wu XP; Cai TP; Wang L; Sun J; Liang JY; Ma SP; Gan X; Ruan NH; Ge SF Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):118-125. PubMed ID: 37137825 [No Abstract] [Full Text] [Related]
13. Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, "real-life" trial. Luo XD; Chen XF; Zhou Y; Chen XP J Viral Hepat; 2017 Nov; 24 Suppl 1():36-42. PubMed ID: 29082651 [TBL] [Abstract][Full Text] [Related]
14. Virological Determinants of Spontaneous Postpartum e Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus. Hu Y; Feng Z; Liu J; Chen J; Zhang S; Zhou YH Arch Med Res; 2016 Apr; 47(3):207-13. PubMed ID: 27387022 [TBL] [Abstract][Full Text] [Related]
15. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA. Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study. Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831 [TBL] [Abstract][Full Text] [Related]
17. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients]. Ling N; Zhou Z; Zhang DZ; Ren H Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission]. Lu JF; Liu YL; Ma LN; Cao ZH; He ZM; Jin Y; Zhang SB; Chen XY Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):821-5. PubMed ID: 26743241 [TBL] [Abstract][Full Text] [Related]
19. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. Bzowej NH; Tran TT; Li R; Belle SH; Smith CI; Khalili M; Chung R; Tsai N; Terrault N; Am J Gastroenterol; 2019 Aug; 114(8):1283-1291. PubMed ID: 31082876 [TBL] [Abstract][Full Text] [Related]
20. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]